Literature DB >> 11083755

Evaluation of large scale clinical trials and their application to usual practice.

A M Tonkin1.   

Abstract

Mesh:

Year:  2000        PMID: 11083755      PMCID: PMC1729533          DOI: 10.1136/heart.84.6.679

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  11 in total

1.  Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect.

Authors:  F A McAlister; A Laupacis; G A Wells; D L Sackett
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

Review 2.  Cause of death in clinical research: time for a reassessment?

Authors:  M S Lauer; E H Blackstone; J B Young; E J Topol
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

Review 3.  Cost effectiveness of the implantable cardioverter defibrillator.

Authors:  P R Roberts; T R Betts; J M Morgan
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

4.  Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey.

Authors:  N Steel
Journal:  BMJ       Date:  2000-05-27

Review 5.  Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading.

Authors:  L Smeeth; A Haines; S Ebrahim
Journal:  BMJ       Date:  1999-06-05

6.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Authors:  B Pitt; P A Poole-Wilson; R Segal; F A Martinez; K Dickstein; A J Camm; M A Konstam; G Riegger; G H Klinger; J Neaton; D Sharma; B Thiyagarajan
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

7.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

Authors:  D Wood; G De Backer; O Faergeman; I Graham; G Mancia; K Pyörälä
Journal:  Atherosclerosis       Date:  1998-10       Impact factor: 5.162

8.  Thrombolytic therapy and equivalence trials.

Authors:  H D White
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

9.  A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society.

Authors:  A Cohen-Solal; M Desnos; F Delahaye; J P Emeriau; G Hanania
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

10.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors:  D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

View more
  1 in total

1.  Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment.

Authors:  Cristiana Vitale; Giuseppe Rosano; Massimo Fini
Journal:  Wien Klin Wochenschr       Date:  2016-09-21       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.